MedTrace Logo

Catheter Ablation in Congenital Heart Disease: French National Prospective Registry

NCT04202796 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-03-09

No results posted yet for this study

Summary

Arrhythmias represent one of the main late complications in patients with congenital heart disease. Atrial arrhythmias are associated with a significant morbidity and are the first cause of urgent hospitalization, and sudden death from ventricular arrhythmias is a leading cause of death in this population.

The exponential increase of the number of patients with congenital heart disease and the improvement of ablative technologies are associated with a significant increase of the number of catheter ablation procedures.

Most of available studies are retrospective or include a limited number of patients.

The aim of this study is to assess the efficacy of catheter ablation in patients with congenital heart disease through a national prospective registry. Secondary objectives are i) to identify factors associated with catheter ablation efficacy in different cardiac defects, ii) to describe complications associated with catheter ablation in this specific population, and iii) to assess the impact of catheter ablation on quality of life of patients with congenital heart disease.

Conditions

Interventions

PROCEDURE

Catheter ablation

Catheter ablation of arrhythmia

Sponsors & Collaborators

  • European Georges Pompidou Hospital

    collaborator OTHER

  • Centre Chirurgical Marie Lannelongue

    collaborator OTHER

  • Clinique Pasteur Toulouse

    collaborator OTHER

  • Paris Cardiovascular Research Center (Inserm U970)

    lead OTHER_GOV

Principal Investigators

  • Victor Waldmann, MD, MPH · Paris Cardiovascular Research Center (Inserm U970)

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-12-31
Completion
2023-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04202796 on ClinicalTrials.gov